A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates.
暂无分享，去创建一个
P. Pilié | G. Manyam | A. Hoang | B. Chapin | L. Chery | A. Kamat | Marisa Lozano | John F. Ward | Andrew W Hahn | Curtis A Pettaway | Chad D. Huff | John W Davis | Xuemei Wang | John Papadopoulos | L. Pisters | Miao Zhang | Yao Yu | J.R. Gregg | Bradley Broom | Christopher J. Logothetis | Patricia Troncoso